Graves' disease is?an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism). Although a number of disorders may result in hyperthyroidism, Graves' disease is a common cause. Thyroid hormones affect many body systems, so signs and symptoms of Graves' disease can be wide ranging.
Graves Disease Treatment Market contains market size and forecasts of Graves Disease Treatment in global, including the following market information:
- Global Graves Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Graves Disease Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Graves Disease Treatment companies in 2021 (%)
The global Graves Disease Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-Thyroid Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Graves Disease Treatment include Abbott, GlaxoSmithKline plc, Merck & Co, Pfizer, Inc, RLC LABS, AbbVie, Inc, Mylan N.V, Allergan, plc and Novartis AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Graves Disease Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Graves Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Graves Disease Treatment Market Segment Percentages, by Type, 2021 (%)
- Anti-Thyroid Medication
- Radioactive Iodine Therapy
Global Graves Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Graves Disease Treatment Market Segment Percentages, by Application, 2021 (%)
- Hospitals Pharmacies
- Retail Pharmacies
Global Graves Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Graves Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Graves Disease Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Graves Disease Treatment revenues share in global market, 2021 (%)
- Key companies Graves Disease Treatment sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Graves Disease Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott
- GlaxoSmithKline plc
- Merck & Co
- Pfizer, Inc
- RLC LABS
- AbbVie, Inc
- Mylan N.V
- Allergan, plc
- Novartis AG
- Apitope
- Amgen INC.
- Sun Pharmaceuticals Industries LTD
- Immunovant Inc
Industry Market Size
